magnolol has been researched along with Stomach Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iqbal, F; Khan, M; Ma, T; Rasul, A; Yang, H; Yu, B; Zhang, K | 1 |
1 other study(ies) available for magnolol and Stomach Neoplasms
| Article | Year |
|---|---|
Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/Akt signaling pathways.
Topics: Adenocarcinoma; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Caspase 3; Cell Growth Processes; Down-Regulation; Enzyme Activation; Humans; Lignans; Mitochondria; Phosphatidylinositol 3-Kinases; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-bcl-2; S Phase; Signal Transduction; Stomach Neoplasms | 2012 |